TRS
NASD TriMas Corporation$39.12 ↑ +0.00 (+0.00%) Trading Up from the previous close of $39.12, $0.19 below the day’s high of $39.31
- YTD change
- +10.35%
- vs 20-day SMA
- +0.98%
- vs 200-day SMA
- +2.21%
Price ranges
Price & Performance
+3.67 (+10.35%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 13.9% away from all-time highs of $45.43
- TRS is up 10% since the beginning of the year
- TRS is up 4% over the past 12 months
- TRS is down 0% over the past 1 month
- 13% of all TRS investors are betting against TRS
TRS reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +3.7%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -0.89%
- vs 8-day SMA
- +0.18%
No alerts for TRS in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. It operates through the following segments: Packaging and Specialty Products. The Packaging segment develops and manufactures dispensing products, polymeric and steel caps and closures, polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical products. The Specialty Products segment focuses on designing, manufacturing, and distribution of highly-engineered steel cylinders for use within industrial and aerospace markets. The company was founded by Brian P. Campbell in 1986 and is headquartered in Bloomfield Hills, MI.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.